Jason Sheehan, Professor of Neurosurgery at the University of Virginia, shared a post on X about a recent paper by him and colleagues published in Journal of Neuro-Oncology:

“Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials”

Authors: Ali Motamed-Sanaye, Ali Mortezaei, Amir Afshari, Zahra Saadatian, Amir Faraji, Jason Sheehan and Ali Mohammad Mokhtari.

Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management

“In Journal of Neuro-Oncology, a new study arising from research by me and other colleagues details the role of angiogenesis inhibitors on glioblastoma management.”

Ali Mortezaei, Research Assistant at Ghaem Hospital, shared this post, adding:

“Grateful to Dr. Jason Sheehan and Dr. Amir Faraji for their invaluable contributions and supervision on this important study, advancing our understanding of angiogenesis inhibitors in GBM management.”